Clinical Trial Update: A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

View source ↗

Summary

This document reports a long-term follow-up study of patients treated with ARD103 CAR-T cell therapy for acute myeloid leukemia (relapsed or refractory) and not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• ARD103 CAR-T cell therapy

Snippet

Sponsor: ARCE Therapeutics, Inc. | Conditions: Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapsed or Refractory | Status: NOT_YET_RECRUITING